{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:38:56Z","timestamp":1788910736749,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jad.2024.09.038","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T07:30:28Z","timestamp":1725953428000},"page":"320-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial"],"prefix":"10.1016","volume":"368","author":[{"given":"Qing-Bin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Cheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Wei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Balbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.09.038_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/YCT.0b013e31824f8296","article-title":"Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting","volume":"28","author":"Abdallah","year":"2012","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2024.09.038_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/YCT.0000000000000632","article-title":"Effects of ketamine anesthesia on efficacy, tolerability, seizure response, and neurocognitive outcomes in electroconvulsive therapy a comprehensive meta-analysis of double-blind randomized controlled trials","volume":"36","author":"Ainsworth","year":"2020","journal-title":"Journal of Ect"},{"key":"10.1016\/j.jad.2024.09.038_bb0015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","article-title":"Treatment resistant depression: a multi-scale, systems biology approach","volume":"84","author":"Akil","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2024.09.038_bb0020","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2024.09.038_bb0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S2215-0366(17)30077-9","article-title":"Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial","volume":"4","author":"Anderson","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/YCT.0000000000000133","article-title":"Electroconvulsive therapy, hypertensive surge, blood-brain barrier breach, and amnesia: exploring the evidence for a connection","volume":"30","author":"Andrade","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2024.09.038_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114058","article-title":"Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: a comparative, randomized and double-blind study","volume":"303","author":"Ara\u00fajo-de-Freitas","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0040","series-title":"Diagnostic and Statistical Manual of Mental Disorders \u2014 (DSM-IV)","author":"Association, A.P","year":"1994"},{"key":"10.1016\/j.jad.2024.09.038_bb0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.9758\/cpn.2019.17.4.523","article-title":"Can propofol lead to an increase in seizure threshold over the course of electroconvulsive therapy?","volume":"17","author":"Aytuluk","year":"2019","journal-title":"Clinical Psychopharmacology and Neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.09.038_bb0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2015.06.003","article-title":"Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant","volume":"68","author":"Ballard","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the Scale for Suicide Ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2024.09.038_bb0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2014.12.054","article-title":"Clinical efficacy of formula-based bifrontal versus right unilateral electroconvulsive therapy (ECT) in the treatment of major depression among elderly patients: a pragmatic, randomized, assessor-blinded, controlled trial","volume":"175","author":"Bj\u00f8lseth","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.09.038_bb0065","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(18)30295-2","article-title":"Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial","volume":"391","author":"Blumberger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2024.09.038_bb0070","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/JCP.0000000000001465","article-title":"Esketamine nasal spray for the rapid reduction of depressive symptoms in major depressive disorder with acute suicidal ideation or behavior","volume":"41","author":"Canuso","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.09.038_bb0075","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41416-022-01937-w","article-title":"Interpreting the results of noninferiority trials-a review","volume":"127","author":"Cuzick","year":"2022","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.jad.2024.09.038_bb0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2024.09.038_bb0090","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1192\/bjp.bp.116.189134","article-title":"Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial","volume":"210","author":"Fernie","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.09.006","article-title":"The MATRICS initiative: developing a consensus cognitive battery for clinical trials","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.psychres.2011.02.022","article-title":"Verbal learning and memory in depression: a 9-year follow-up study","volume":"188","author":"Halvorsen","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2147\/DDDT.S401161","article-title":"Effect of subanesthetic dose of esketamine on perioperative neurocognitive disorders in elderly undergoing gastrointestinal surgery: a randomized controlled trial","volume":"17","author":"Han","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jad.2024.09.038_bb0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psc.2018.04.001","article-title":"Electroconvulsive therapy in depression: current practice and future direction","volume":"41","author":"Hermida","year":"2018","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2024.09.038_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0893-133X(01)00229-9","article-title":"Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically","volume":"25","author":"Holcomb","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.09.038_bb0125","first-page":"255","article-title":"Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study","volume":"264","author":"Hoyer","year":"2014","journal-title":"Eur Arch Psy Clin N"},{"key":"10.1016\/j.jad.2024.09.038_bb0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5152\/alphapsychiatry.2023.231358","article-title":"Ketamine and electroconvulsive therapy for treatment-refractory depression","volume":"24","author":"Huang","year":"2023","journal-title":"Alpha Psychiat."},{"key":"10.1016\/j.jad.2024.09.038_bb0135","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2147\/NDT.S134503","article-title":"Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy","volume":"13","author":"Joo","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2024.09.038_bb0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1017\/S1461145714000017","article-title":"Lavender oil preparation Silexan is effective in generalized anxiety disorder\u2014a randomized, double-blind comparison to placebo and paroxetine","volume":"17","author":"Kasper","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2024.09.038_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/HRP.0000000000000365","article-title":"Electroconvulsive therapy: mechanisms of action, clinical considerations, and future directions","volume":"31","author":"Kritzer","year":"2023","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1176\/jnp.15.1.27","article-title":"Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT","volume":"15","author":"Krystal","year":"2003","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.09.038_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4306\/pi.2010.7.4.231","article-title":"The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment","volume":"7","author":"Lee","year":"2010","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2024.09.038_bb0160","first-page":"150","article-title":"Superiority, equivalence, and non-inferiority trials","volume":"66","author":"Lesaffre","year":"2008","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.jad.2024.09.038_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2018.10.105","article-title":"Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT","volume":"245","author":"Lin","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.09.038_bb0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/YCT.0b013e3181e48143","article-title":"Augmentation strategies in electroconvulsive therapy","volume":"26","author":"Loo","year":"2010","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2024.09.038_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2009.07.011","article-title":"The difficult-to-treat electroconvulsive therapy patient - strategies for augmenting outcomes","volume":"124","author":"Loo","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.09.038_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0327(88)90072-9","article-title":"The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders","volume":"14","author":"Maier","year":"1988","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.09.038_bb0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1192\/bjp.bp.116.195826","article-title":"Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis","volume":"210","author":"McGirr","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach","volume":"156","author":"McIntyre","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.09.038_bb0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0200","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamapsychiatry.2023.0562","article-title":"Ketamine vs electroconvulsive therapy for major depressive episode: a systematic review and meta-analysis","volume":"80","author":"Menon","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-018-0519-3","article-title":"Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review","volume":"32","author":"Molero","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2024.09.038_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0215","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00213-018-4828-5","article-title":"Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study","volume":"235","author":"Morrison","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.09.038_bb0220","first-page":"1","article-title":"Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response","author":"Murrough","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.09.038_bb0225","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/npp.2014.298","article-title":"Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial","volume":"40","author":"Murrough","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.09.038_bb0230","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/YCT.0b013e3181c3b0aa","article-title":"Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia","volume":"26","author":"Okamoto","year":"2010","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2024.09.038_bb0240","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2024.09.038_bb0245","first-page":"138","article-title":"The \u201chalf-age\u201d stimulation strategy for ECT dosing","volume":"12","author":"Petrides","year":"1996","journal-title":"Convuls. Ther."},{"key":"10.1016\/j.jad.2024.09.038_bb0250","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression","volume":"45","author":"Phillips","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.09.038_bb0255","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated Oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/YCT.0000000000000093","article-title":"Propofol for ECT anesthesia a review of the literature","volume":"30","author":"Rasmussen","year":"2014","journal-title":"Journal of Ect"},{"key":"10.1016\/j.jad.2024.09.038_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115843","article-title":"Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: a pragmatic, randomized, controlled trial","volume":"335","author":"Ren","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0270","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jamapsychiatry.2022.3352","article-title":"Efficacy and safety of ketamine vs electroconvulsive therapy among patients with major depressive episode: a systematic review and meta-analysis","volume":"79","author":"Rhee","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0275","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0280","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/YCT.0000000000000317","article-title":"Ketamine anesthesia, efficacy of electroconvulsive therapy, and cognitive functions in treatment-resistant depression","volume":"32","author":"Rybakowski","year":"2016","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2024.09.038_bb0285","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00406-020-01170-7","article-title":"Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality","volume":"271","author":"Sartorius","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.09.038_bb0290","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00000542-200003000-00017","article-title":"Population pharmacokinetics of propofol: a multicenter study","volume":"92","author":"Schuttler","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jad.2024.09.038_bb0295","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/appi.ajp.2015.15030372","article-title":"Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial","volume":"173","author":"Semkovska","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103720","article-title":"Ketamine versus electroconvulsive therapy for treatment-resistant depression: an updated meta-analysis of randomized clinical trials","volume":"88","author":"Shafiee","year":"2023","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2024.09.038_bb0305","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpsychires.2021.03.009","article-title":"Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: a systematic review","volume":"137","author":"Siegel","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.eplepsyres.2011.08.007","article-title":"Differences in cerebral blood flow between missed and generalized seizures with electroconvulsive therapy: a positron emission tomographic study","volume":"97","author":"Takano","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0315","first-page":"64","article-title":"Hamilton Anxiety Scale (HAMA) [in Chinese]","author":"Tang","year":"1984","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/YCT.0b013e31825957b1","article-title":"Electroconvulsive therapy in China: clinical practice and research on efficacy","volume":"28","author":"Tang","year":"2012","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2024.09.038_bb0325","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3892\/etm.2021.10716","article-title":"Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (review)","volume":"22","author":"Trifu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jad.2024.09.038_bb0330","first-page":"159","article-title":"Reliability and validity of BSI-CV in evaluating the depression patients [in Chinese]","volume":"20","author":"Wang","year":"2012","journal-title":"Chin. J. Health Psychol."},{"key":"10.1016\/j.jad.2024.09.038_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172870","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","volume":"190","author":"Wei","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2024.09.038_bb0340","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5152\/alphapsychiatry.2023.231401","article-title":"Optimization strategies of transcranial magnetic stimulation in major depressive disorder","volume":"24","author":"Wen","year":"2023","journal-title":"Alpha Psychiatry"},{"key":"10.1016\/j.jad.2024.09.038_bb0345","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YCT.0000000000000132","article-title":"Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial","volume":"31","author":"Yen","year":"2015","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2024.09.038_bb0350","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00406-017-0800-3","article-title":"S -ketamine compared to etomidate during electroconvulsive therapy in major depression","volume":"267","author":"Zavorotnyy","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2024.09.038_bb0355","series-title":"Manual of Psychiatric Rating Scales [in Chinese]","author":"Zhang","year":"1998"},{"key":"10.1016\/j.jad.2024.09.038_bb0360","first-page":"238","article-title":"Reliability and validity of Hamilton Depression Scale assessed in 329 Chinese depression patients [in Chinese]","volume":"214-216","author":"Zhao","year":"1992","journal-title":"Chin. Ment. Health J."},{"key":"10.1016\/j.jad.2024.09.038_bb0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.09.038_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2019.02.044","article-title":"Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: a meta-analysis of randomized controlled trials","volume":"250","author":"Zheng","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.09.038_bb0375","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jad.2018.12.005","article-title":"Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder","volume":"246","author":"Zheng","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.09.038_bb0380","first-page":"85","article-title":"Reliability, validity and sensitivity of Montgomery-Asberg depression rating scale for patients with current major depression disorder [in Chinese]","volume":"20","author":"Zhong","year":"2011","journal-title":"Chin. J. Behav. Med. Brain Sci."},{"key":"10.1016\/j.jad.2024.09.038_bb0385","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2016.05.011","article-title":"Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression","volume":"201","author":"Zhong","year":"2016","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724015301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724015301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T10:06:56Z","timestamp":1730887616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724015301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":77,"alternative-id":["S0165032724015301"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.09.038","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}